$JLL

Quinlan Larry sold $121K of JLL

Quinlan Larry sold 402 shares of JONES LANG LASALLE INC (JLL) at $301.73 ($0.12M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Quinlan Larry
Published Jun 16, 2026, 3:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 3:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$JLL
Neutral
high confidence
Mentioned
$JLL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JLLNeutralLow
01

Why it matters

This is primarily a sentiment/positioning datapoint rather than a fundamental catalyst; the 10b5-1 designation generally implies the trades were scheduled in advance.

02

Market read

Traders may briefly reassess near-term sentiment around insider activity, but the disclosure is unlikely to drive a durable repricing without additional company news.

03

What to watch

The article provides only the sale size and plan type; it does not indicate whether other insiders bought, whether the director’s overall holdings changed materially over time, or whether there were concurrent corporate events.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-16; sale executed 2026-06-12

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for JLL, reporting a director’s open-market sale.

Company-level read

Ticker impact

$JLLNeutralHigh confidence
Context

SEC Form 4 shows director Quinlan Larry sold 402 shares of JLL on 2026-06-12 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief unless accompanied by other new company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 pre-arranged plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal—single insider transaction in a large RE/real-estate services name does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read by some traders as confidence erosion, especially if it contrasts with prior buying patterns.

Key entities

  • JLL

    Jones Lang LaSalle Inc.; subject of the Form 4 insider transaction disclosure.

  • Quinlan Larry

    Director who sold 402 shares on 2026-06-12 under a pre-arranged 10b5-1 plan.

Related articles

$JLLMed

Jones Lang LaSalle Incorporated Q2 2026 Earnings Call Summary

Jones Lang LaSalle (JLL) reported Q2 2026 results driven by its “One JLL” strategy and resilient business lines. Management raised full-year 2026 adjusted EPS guidance to $24.60–$25.90 and targeted mid-to-high teens leasing and mid-teens capital markets revenue growth. It cited advisory revenue up 21%, office bifurcation, and risks from slower capital raising.

$JLLMedAI 8/10

JLL (JLL) Q2 2026 Earnings Call Transcript

Jul. 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Head of Investor Relations - Sean Coghlan President and Chief Executive Officer - Christian Ulbrich Chief Financial Officer - Kelly Howe TAKEAWAYS Revenue Growth -- 11% reported in U.S. dollars and 10% in local currency, driven by organic momentum in advisory businesses, particularly in the U.S. market.

$JLLMedAI 8/10

JLL Reports High Revenue Growth in Q2 Despite Global Conflict

JLL reported Q2 results with cash flow from operations of $488.1 million versus $332.8 million a year earlier. Revenue rose to $6.9 billion from $6.2 billion, and net income increased to $373.7 million from $168 million, according to the company. Net debt fell to $1.1 billion from $1.4 billion. JLL cited global conflict and interest-rate shifts but expects no major slowdown.

$JLLMed

JLL’s (NYSE:JLL) Q2 CY2026 Sales Beat Estimates

JLL (NYSE:JLL) reported Q2 CY2026 revenue of $6.93 billion, up 10.8% year on year and 1.5% above estimates, according to the company. Non-GAAP adjusted EPS was $5.26, 15.6% above analysts’ consensus. Operating margin was 4.2% in Q2. Analysts project revenue growth of 8.5% over the next 12 months.